Product Program year 2024 Source: CMS Open Payments

Eterna

Device Neuromodulation

PDI 05415067040763

Open in the dashboard

General payments

$825,035

21,792 payments

Research payments

$3,806

1 payment

Through program year 2024, $825,035 in general payments and $3,806 in research payments were reported against Eterna (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $632,135 15,797
2024 Research $3,806 1
2023 General $192,900 5,995

Breakdown

Who paid General payments · program years 2023–2024
  1. Abbott Laboratories $825,035 21,792 payments
Top recipients General payments · program year 2024
  1. Marcin Karcz Critical Care Medicine · Bronxville, NY $2,732 <1% · 37 payments
  2. Lucas Bracero Pain Medicine · Charleston, WV $2,695 <1% · 36 payments
  3. Tolga Suvar Anesthesiology · Chicago, IL $2,613 <1% · 37 payments
  4. Boca Raton Regional Hospital Teaching hospital · FL $2,500 <1% · 1 payment
  5. Thomas Weber Anesthesiology · Raleigh, NC $2,159 <1% · 27 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pain Medicine Anesthesiology $122,131 20% · 760 practitioners
  2. Interventional Pain Medicine Pain Medicine $82,713 13% · 530 practitioners
  3. Physician Assistant $57,132 9% · 523 practitioners
  4. Anesthesiology $45,929 7% · 281 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $43,930 7% · 497 practitioners

The top 5 of 136 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $68,837 11% · 668 recipients
  2. Florida $50,462 8% · 545 recipients
  3. Illinois $47,766 8% · 271 recipients
  4. California $42,047 7% · 509 recipients
  5. Arizona $40,964 6% · 300 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

21,792 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record